Company intelligence / Profile preview
Liaoning Chengda Biotechnology Co., Ltd.
- Ownership
- Private
- Employees
- ~1732
- Development stage
- Commercial
Overview
The company has two approved vaccines in the market: Rabies Vaccine for Human Use (SPEEDA®) and Inactivated Japanese Encephalitis Vaccine (JEVAC®). The rabies vaccine has been sold in more than 30 countries with 400 million doses without any immunization failure. Several other vaccines are in various stages of development, including a Tetravalent influenza vaccine at NDA/BLA stage, a Recombinant Fifteen Valent Human Papillomavirus Vaccine in Phase 2, and a Haemophilus Influenzae Type b Conjugate Vaccine in Phase 1.
- Therapeutic areas
- Infectious Diseases
- Modalities
- Vaccines (Prophylactic vaccinesCombination vaccinesConjugated vaccinesMultivalent vaccinesLive attenuated vaccinesRecombinant protein vaccines)
- Industry
- Biotech
Drug pipeline
7 assets6 more assets in the full pipeline.
Request access →Beyond the preview
Go deeper on Liaoning Chengda Biotechnology Co., Ltd..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Liaoning Chengda Biotechnology Co., Ltd..